K.A.B.S.
Desconocido
Impentri: Development of Impentri an intravenous imatinib formulation for Covid 19 acute respiratory distress...
K.A.B.S. LABORATORIES INC. KABS
participó en un
H2020:
H2020-JTI-IMI2-2020-21-single-stage
The accumulation of fluid in the lungs is a significant feature of the pathology in patients with severe Covid-19 infection. This build up o...
2020-08-07 - 2022-10-31 | Financiado
2020-08-07 - 2022-10-31 | Financiado
ELIMOX: Biopharmaceutical therapy for treatment of Primary Hyperoxaluria
Interest in the use of naturally occurring human gut bacteria as pharmaceutical drugs has increased as knowledge about the human microbiota...
Financiado
Financiado
* No se disponen de datos de la empresa actual.